The Gladstone Foundation is a nonprofit organization that provides financial and advisory support to Gladstone Institutes. Established in 2011, this volunteer organization is composed of dedicated leaders who understand that the search for global cures must begin with deep biological knowledge and research.
Gladstone Foundation Board of Directors
Chair
William H. Younger, Jr.
Retired Managing Director, Sutter Hill Ventures
Vice Chair
Stasia A. Obremskey
Strategy Director, Contraceptive Technology Development, Rhia Ventures
Board Members
Chris Boskin
Media Consultant
Marianne De Backer, PhD, MBA
Head of Pharmaceuticals Business Development and Licensing, Bayer
Paul C. Edwards
Edwards Partners
Sakurako D. Fisher
Former President, San Francisco Symphony
Tom Furst
Retired CFO, SRI International
Linda Grais, MD, JD
Former President and CEO, Ocera Therapeutics
Erin Hoffmann
President and Co-Founder at Additional Ventures
Perry Karsen
Former CEO, Celgene Cellular Therapeutics and EVP, Chief Operations Officer of Celgene Corporation
Li Lu
Founder and Chairman, Himalaya Capital
Diksha Makan
Senior Vice President of Technology Strategy, ICONIQ Capital
Gary Morgenthaler
Partner, Morgenthaler Ventures
Deep V. Nishar
Managing Director, General Catalyst
Christopher R. Redlich, Jr.
Philanthropist
Steve Richardson
CEO, Alexandria Real Estate
Douglas G. Scrivner
Retired General Counsel, Accenture
Deepak Srivastava, MD
President, Gladstone Institutes
Director, Roddenberry Stem Cell Center
James B. Tananbaum, MD
Founder, CEO, and Managing Director, Foresite Capital Management
R. Sanders Williams, MD
President Emeritus, Gladstone Institutes
Sharon Winslow
Attorney
Board Officers
Chris Nicholson
Secretary
Michelle Sibly
Treasurer
Robert Wicks
CEO